Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)

NCT02101411 is registered in ClinicalTrials.gov with Taipei City Hospital as lead sponsor.

NCT NCT02101411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02101411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)
Lead sponsor
Taipei City Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
October 1, 2016
Enrollment
334 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apt(antiplatelet therapy), hotpr(high on treat platelet reactivity), pru(platelet reactivity unit)